nodes	percent_of_prediction	percent_of_DWPC	metapath
Efavirenz—CYP2C9—brain cancer	0.547	1	CbGaD
Efavirenz—CYP2D6—Lomustine—brain cancer	0.0677	0.218	CbGbCtD
Efavirenz—CYP1A2—Carmustine—brain cancer	0.067	0.216	CbGbCtD
Efavirenz—CYP2D6—Hydroxyurea—brain cancer	0.0513	0.166	CbGbCtD
Efavirenz—CYP3A4—Temozolomide—brain cancer	0.0507	0.163	CbGbCtD
Efavirenz—CYP3A4—Lomustine—brain cancer	0.0431	0.139	CbGbCtD
Efavirenz—CYP1A2—Etoposide—brain cancer	0.0199	0.0641	CbGbCtD
Efavirenz—CYP3A4—Etoposide—brain cancer	0.0104	0.0336	CbGbCtD
Efavirenz—CYP2B6—CYP2E1 reactions—CYP2C9—brain cancer	0.000776	0.0633	CbGpPWpGaD
Efavirenz—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000756	0.0617	CbGpPWpGaD
Efavirenz—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000688	0.0562	CbGpPWpGaD
Efavirenz—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000589	0.0481	CbGpPWpGaD
Efavirenz—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.000586	0.0478	CbGpPWpGaD
Efavirenz—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.000539	0.044	CbGpPWpGaD
Efavirenz—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000536	0.0438	CbGpPWpGaD
Efavirenz—CYP2B6—Xenobiotics—CYP2C9—brain cancer	0.000481	0.0392	CbGpPWpGaD
Efavirenz—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000363	0.0297	CbGpPWpGaD
Efavirenz—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000349	0.0285	CbGpPWpGaD
Efavirenz—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000334	0.0273	CbGpPWpGaD
Efavirenz—CYP2B6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00033	0.0269	CbGpPWpGaD
Efavirenz—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000321	0.0262	CbGpPWpGaD
Efavirenz—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000315	0.0257	CbGpPWpGaD
Efavirenz—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000283	0.0231	CbGpPWpGaD
Efavirenz—Hyperhidrosis—Procarbazine—brain cancer	0.00028	0.00214	CcSEcCtD
Efavirenz—Renal failure—Carmustine—brain cancer	0.000279	0.00214	CcSEcCtD
Efavirenz—Alopecia—Hydroxyurea—brain cancer	0.000279	0.00213	CcSEcCtD
Efavirenz—Neuropathy peripheral—Carmustine—brain cancer	0.000279	0.00213	CcSEcCtD
Efavirenz—Hyperglycaemia—Temozolomide—brain cancer	0.000278	0.00213	CcSEcCtD
Efavirenz—Pneumonia—Temozolomide—brain cancer	0.000276	0.00211	CcSEcCtD
Efavirenz—Anorexia—Procarbazine—brain cancer	0.000276	0.00211	CcSEcCtD
Efavirenz—Erythema—Hydroxyurea—brain cancer	0.000275	0.0021	CcSEcCtD
Efavirenz—Infestation—Temozolomide—brain cancer	0.000275	0.0021	CcSEcCtD
Efavirenz—Infestation NOS—Temozolomide—brain cancer	0.000275	0.0021	CcSEcCtD
Efavirenz—Depression—Temozolomide—brain cancer	0.000274	0.0021	CcSEcCtD
Efavirenz—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000272	0.00208	CcSEcCtD
Efavirenz—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000272	0.0222	CbGpPWpGaD
Efavirenz—Nausea—Lomustine—brain cancer	0.000271	0.00207	CcSEcCtD
Efavirenz—Neuropathy peripheral—Temozolomide—brain cancer	0.000269	0.00206	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000264	0.00202	CcSEcCtD
Efavirenz—Insomnia—Procarbazine—brain cancer	0.000262	0.002	CcSEcCtD
Efavirenz—Paraesthesia—Procarbazine—brain cancer	0.00026	0.00199	CcSEcCtD
Efavirenz—Hepatobiliary disease—Temozolomide—brain cancer	0.00026	0.00199	CcSEcCtD
Efavirenz—Sinusitis—Temozolomide—brain cancer	0.000258	0.00197	CcSEcCtD
Efavirenz—Somnolence—Procarbazine—brain cancer	0.000258	0.00197	CcSEcCtD
Efavirenz—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000257	0.00196	CcSEcCtD
Efavirenz—Ill-defined disorder—Hydroxyurea—brain cancer	0.000255	0.00195	CcSEcCtD
Efavirenz—Anaemia—Hydroxyurea—brain cancer	0.000254	0.00194	CcSEcCtD
Efavirenz—Hallucination—Carmustine—brain cancer	0.000254	0.00194	CcSEcCtD
Efavirenz—Hypoaesthesia—Carmustine—brain cancer	0.000254	0.00194	CcSEcCtD
Efavirenz—Decreased appetite—Procarbazine—brain cancer	0.000252	0.00193	CcSEcCtD
Efavirenz—Oedema peripheral—Carmustine—brain cancer	0.000251	0.00192	CcSEcCtD
Efavirenz—Connective tissue disorder—Carmustine—brain cancer	0.000251	0.00192	CcSEcCtD
Efavirenz—Fatigue—Procarbazine—brain cancer	0.00025	0.00191	CcSEcCtD
Efavirenz—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000249	0.0204	CbGpPWpGaD
Efavirenz—Malaise—Hydroxyurea—brain cancer	0.000248	0.0019	CcSEcCtD
Efavirenz—Constipation—Procarbazine—brain cancer	0.000248	0.0019	CcSEcCtD
Efavirenz—Pain—Procarbazine—brain cancer	0.000248	0.0019	CcSEcCtD
Efavirenz—Hepatitis—Temozolomide—brain cancer	0.000247	0.00189	CcSEcCtD
Efavirenz—Visual impairment—Carmustine—brain cancer	0.000246	0.00188	CcSEcCtD
Efavirenz—Hypoaesthesia—Temozolomide—brain cancer	0.000245	0.00188	CcSEcCtD
Efavirenz—Hallucination—Temozolomide—brain cancer	0.000245	0.00188	CcSEcCtD
Efavirenz—Urinary tract disorder—Temozolomide—brain cancer	0.000244	0.00186	CcSEcCtD
Efavirenz—Oedema peripheral—Temozolomide—brain cancer	0.000243	0.00186	CcSEcCtD
Efavirenz—Connective tissue disorder—Temozolomide—brain cancer	0.000242	0.00185	CcSEcCtD
Efavirenz—Urethral disorder—Temozolomide—brain cancer	0.000242	0.00185	CcSEcCtD
Efavirenz—Sweating increased—Etoposide—brain cancer	0.00024	0.00184	CcSEcCtD
Efavirenz—Feeling abnormal—Procarbazine—brain cancer	0.000239	0.00183	CcSEcCtD
Efavirenz—Eye disorder—Carmustine—brain cancer	0.000239	0.00182	CcSEcCtD
Efavirenz—Convulsion—Hydroxyurea—brain cancer	0.000238	0.00182	CcSEcCtD
Efavirenz—Visual impairment—Temozolomide—brain cancer	0.000238	0.00182	CcSEcCtD
Efavirenz—Gastrointestinal pain—Procarbazine—brain cancer	0.000237	0.00181	CcSEcCtD
Efavirenz—Flushing—Carmustine—brain cancer	0.000237	0.00181	CcSEcCtD
Efavirenz—Pancytopenia—Etoposide—brain cancer	0.000234	0.00179	CcSEcCtD
Efavirenz—Erythema multiforme—Temozolomide—brain cancer	0.000233	0.00178	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000232	0.00178	CcSEcCtD
Efavirenz—Discomfort—Hydroxyurea—brain cancer	0.000231	0.00177	CcSEcCtD
Efavirenz—Eye disorder—Temozolomide—brain cancer	0.00023	0.00176	CcSEcCtD
Efavirenz—Urticaria—Procarbazine—brain cancer	0.00023	0.00176	CcSEcCtD
Efavirenz—Tinnitus—Temozolomide—brain cancer	0.00023	0.00176	CcSEcCtD
Efavirenz—Body temperature increased—Procarbazine—brain cancer	0.000229	0.00175	CcSEcCtD
Efavirenz—Abdominal pain—Procarbazine—brain cancer	0.000229	0.00175	CcSEcCtD
Efavirenz—Cardiac disorder—Temozolomide—brain cancer	0.000229	0.00175	CcSEcCtD
Efavirenz—Flushing—Temozolomide—brain cancer	0.000229	0.00175	CcSEcCtD
Efavirenz—Arrhythmia—Carmustine—brain cancer	0.000228	0.00174	CcSEcCtD
Efavirenz—Alopecia—Carmustine—brain cancer	0.000226	0.00172	CcSEcCtD
Efavirenz—Angiopathy—Temozolomide—brain cancer	0.000224	0.00171	CcSEcCtD
Efavirenz—Immune system disorder—Temozolomide—brain cancer	0.000223	0.0017	CcSEcCtD
Efavirenz—Mediastinal disorder—Temozolomide—brain cancer	0.000222	0.0017	CcSEcCtD
Efavirenz—Erythema—Carmustine—brain cancer	0.000222	0.0017	CcSEcCtD
Efavirenz—Malnutrition—Carmustine—brain cancer	0.000222	0.0017	CcSEcCtD
Efavirenz—Pneumonia—Etoposide—brain cancer	0.000221	0.00169	CcSEcCtD
Efavirenz—Nervous system disorder—Hydroxyurea—brain cancer	0.00022	0.00168	CcSEcCtD
Efavirenz—Infestation—Etoposide—brain cancer	0.00022	0.00168	CcSEcCtD
Efavirenz—Infestation NOS—Etoposide—brain cancer	0.00022	0.00168	CcSEcCtD
Efavirenz—Thrombocytopenia—Hydroxyurea—brain cancer	0.00022	0.00168	CcSEcCtD
Efavirenz—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000218	0.0178	CbGpPWpGaD
Efavirenz—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000218	0.00167	CcSEcCtD
Efavirenz—Alopecia—Temozolomide—brain cancer	0.000218	0.00167	CcSEcCtD
Efavirenz—Skin disorder—Hydroxyurea—brain cancer	0.000218	0.00167	CcSEcCtD
Efavirenz—Renal failure—Etoposide—brain cancer	0.000216	0.00165	CcSEcCtD
Efavirenz—Neuropathy peripheral—Etoposide—brain cancer	0.000215	0.00165	CcSEcCtD
Efavirenz—Back pain—Carmustine—brain cancer	0.000215	0.00164	CcSEcCtD
Efavirenz—Malnutrition—Temozolomide—brain cancer	0.000215	0.00164	CcSEcCtD
Efavirenz—Erythema—Temozolomide—brain cancer	0.000215	0.00164	CcSEcCtD
Efavirenz—Jaundice—Etoposide—brain cancer	0.000214	0.00164	CcSEcCtD
Efavirenz—Anorexia—Hydroxyurea—brain cancer	0.000214	0.00164	CcSEcCtD
Efavirenz—Hypersensitivity—Procarbazine—brain cancer	0.000214	0.00163	CcSEcCtD
Efavirenz—Dysgeusia—Temozolomide—brain cancer	0.00021	0.00161	CcSEcCtD
Efavirenz—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.00021	0.0172	CbGpPWpGaD
Efavirenz—Vision blurred—Carmustine—brain cancer	0.000209	0.0016	CcSEcCtD
Efavirenz—Tremor—Carmustine—brain cancer	0.000208	0.00159	CcSEcCtD
Efavirenz—Asthenia—Procarbazine—brain cancer	0.000208	0.00159	CcSEcCtD
Efavirenz—Hepatobiliary disease—Etoposide—brain cancer	0.000208	0.00159	CcSEcCtD
Efavirenz—Back pain—Temozolomide—brain cancer	0.000208	0.00159	CcSEcCtD
Efavirenz—Anaemia—Carmustine—brain cancer	0.000205	0.00157	CcSEcCtD
Efavirenz—Pruritus—Procarbazine—brain cancer	0.000205	0.00157	CcSEcCtD
Efavirenz—Agitation—Carmustine—brain cancer	0.000204	0.00156	CcSEcCtD
Efavirenz—Vision blurred—Temozolomide—brain cancer	0.000202	0.00155	CcSEcCtD
Efavirenz—Tremor—Temozolomide—brain cancer	0.000201	0.00154	CcSEcCtD
Efavirenz—Dyspnoea—Hydroxyurea—brain cancer	0.0002	0.00153	CcSEcCtD
Efavirenz—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.0002	0.0163	CbGpPWpGaD
Efavirenz—Somnolence—Hydroxyurea—brain cancer	0.000199	0.00153	CcSEcCtD
Efavirenz—Ill-defined disorder—Temozolomide—brain cancer	0.000199	0.00152	CcSEcCtD
Efavirenz—Anaemia—Temozolomide—brain cancer	0.000198	0.00152	CcSEcCtD
Efavirenz—Diarrhoea—Procarbazine—brain cancer	0.000198	0.00152	CcSEcCtD
Efavirenz—Dyspepsia—Hydroxyurea—brain cancer	0.000197	0.00151	CcSEcCtD
Efavirenz—Agitation—Temozolomide—brain cancer	0.000197	0.00151	CcSEcCtD
Efavirenz—CYP2B6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000197	0.0161	CbGpPWpGaD
Efavirenz—Hypoaesthesia—Etoposide—brain cancer	0.000196	0.0015	CcSEcCtD
Efavirenz—Angioedema—Temozolomide—brain cancer	0.000196	0.0015	CcSEcCtD
Efavirenz—Decreased appetite—Hydroxyurea—brain cancer	0.000195	0.00149	CcSEcCtD
Efavirenz—Urinary tract disorder—Etoposide—brain cancer	0.000195	0.00149	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000194	0.00148	CcSEcCtD
Efavirenz—Malaise—Temozolomide—brain cancer	0.000194	0.00148	CcSEcCtD
Efavirenz—Urethral disorder—Etoposide—brain cancer	0.000193	0.00148	CcSEcCtD
Efavirenz—Fatigue—Hydroxyurea—brain cancer	0.000193	0.00148	CcSEcCtD
Efavirenz—Vertigo—Temozolomide—brain cancer	0.000193	0.00148	CcSEcCtD
Efavirenz—Convulsion—Carmustine—brain cancer	0.000192	0.00147	CcSEcCtD
Efavirenz—Hypertension—Carmustine—brain cancer	0.000192	0.00147	CcSEcCtD
Efavirenz—Pain—Hydroxyurea—brain cancer	0.000192	0.00147	CcSEcCtD
Efavirenz—Constipation—Hydroxyurea—brain cancer	0.000192	0.00147	CcSEcCtD
Efavirenz—Dizziness—Procarbazine—brain cancer	0.000192	0.00147	CcSEcCtD
Efavirenz—Palpitations—Temozolomide—brain cancer	0.00019	0.00145	CcSEcCtD
Efavirenz—Myalgia—Carmustine—brain cancer	0.000189	0.00145	CcSEcCtD
Efavirenz—Chest pain—Carmustine—brain cancer	0.000189	0.00145	CcSEcCtD
Efavirenz—Anxiety—Carmustine—brain cancer	0.000188	0.00144	CcSEcCtD
Efavirenz—Cough—Temozolomide—brain cancer	0.000187	0.00143	CcSEcCtD
Efavirenz—Erythema multiforme—Etoposide—brain cancer	0.000187	0.00143	CcSEcCtD
Efavirenz—Convulsion—Temozolomide—brain cancer	0.000186	0.00142	CcSEcCtD
Efavirenz—Hypertension—Temozolomide—brain cancer	0.000185	0.00142	CcSEcCtD
Efavirenz—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000185	0.0151	CbGpPWpGaD
Efavirenz—Feeling abnormal—Hydroxyurea—brain cancer	0.000185	0.00141	CcSEcCtD
Efavirenz—Eye disorder—Etoposide—brain cancer	0.000184	0.00141	CcSEcCtD
Efavirenz—Vomiting—Procarbazine—brain cancer	0.000184	0.00141	CcSEcCtD
Efavirenz—Flushing—Etoposide—brain cancer	0.000183	0.0014	CcSEcCtD
Efavirenz—Cardiac disorder—Etoposide—brain cancer	0.000183	0.0014	CcSEcCtD
Efavirenz—Confusional state—Carmustine—brain cancer	0.000183	0.0014	CcSEcCtD
Efavirenz—Arthralgia—Temozolomide—brain cancer	0.000183	0.0014	CcSEcCtD
Efavirenz—Myalgia—Temozolomide—brain cancer	0.000183	0.0014	CcSEcCtD
Efavirenz—Rash—Procarbazine—brain cancer	0.000183	0.0014	CcSEcCtD
Efavirenz—Dermatitis—Procarbazine—brain cancer	0.000183	0.0014	CcSEcCtD
Efavirenz—Anxiety—Temozolomide—brain cancer	0.000182	0.00139	CcSEcCtD
Efavirenz—Headache—Procarbazine—brain cancer	0.000182	0.00139	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000182	0.00139	CcSEcCtD
Efavirenz—Discomfort—Temozolomide—brain cancer	0.000181	0.00138	CcSEcCtD
Efavirenz—Angiopathy—Etoposide—brain cancer	0.000179	0.00137	CcSEcCtD
Efavirenz—Dry mouth—Temozolomide—brain cancer	0.000179	0.00137	CcSEcCtD
Efavirenz—Immune system disorder—Etoposide—brain cancer	0.000178	0.00136	CcSEcCtD
Efavirenz—Mediastinal disorder—Etoposide—brain cancer	0.000178	0.00136	CcSEcCtD
Efavirenz—Thrombocytopenia—Carmustine—brain cancer	0.000178	0.00136	CcSEcCtD
Efavirenz—Body temperature increased—Hydroxyurea—brain cancer	0.000177	0.00136	CcSEcCtD
Efavirenz—Tachycardia—Carmustine—brain cancer	0.000177	0.00135	CcSEcCtD
Efavirenz—Confusional state—Temozolomide—brain cancer	0.000177	0.00135	CcSEcCtD
Efavirenz—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000175	0.0142	CbGpPWpGaD
Efavirenz—Alopecia—Etoposide—brain cancer	0.000174	0.00133	CcSEcCtD
Efavirenz—Anorexia—Carmustine—brain cancer	0.000173	0.00132	CcSEcCtD
Efavirenz—Nausea—Procarbazine—brain cancer	0.000172	0.00132	CcSEcCtD
Efavirenz—Nervous system disorder—Temozolomide—brain cancer	0.000172	0.00131	CcSEcCtD
Efavirenz—Thrombocytopenia—Temozolomide—brain cancer	0.000172	0.00131	CcSEcCtD
Efavirenz—Skin disorder—Temozolomide—brain cancer	0.00017	0.0013	CcSEcCtD
Efavirenz—Hyperhidrosis—Temozolomide—brain cancer	0.000169	0.0013	CcSEcCtD
Efavirenz—Dysgeusia—Etoposide—brain cancer	0.000168	0.00129	CcSEcCtD
Efavirenz—Anorexia—Temozolomide—brain cancer	0.000167	0.00128	CcSEcCtD
Efavirenz—Back pain—Etoposide—brain cancer	0.000166	0.00127	CcSEcCtD
Efavirenz—Hypersensitivity—Hydroxyurea—brain cancer	0.000165	0.00126	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Carmustine—brain cancer	0.000165	0.00126	CcSEcCtD
Efavirenz—Insomnia—Carmustine—brain cancer	0.000164	0.00125	CcSEcCtD
Efavirenz—Paraesthesia—Carmustine—brain cancer	0.000163	0.00125	CcSEcCtD
Efavirenz—CYP2B6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000162	0.0132	CbGpPWpGaD
Efavirenz—Dyspnoea—Carmustine—brain cancer	0.000162	0.00124	CcSEcCtD
Efavirenz—Somnolence—Carmustine—brain cancer	0.000161	0.00123	CcSEcCtD
Efavirenz—Asthenia—Hydroxyurea—brain cancer	0.000161	0.00123	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00016	0.00122	CcSEcCtD
Efavirenz—Ill-defined disorder—Etoposide—brain cancer	0.000159	0.00122	CcSEcCtD
Efavirenz—Anaemia—Etoposide—brain cancer	0.000159	0.00121	CcSEcCtD
Efavirenz—Insomnia—Temozolomide—brain cancer	0.000158	0.00121	CcSEcCtD
Efavirenz—Decreased appetite—Carmustine—brain cancer	0.000158	0.00121	CcSEcCtD
Efavirenz—Paraesthesia—Temozolomide—brain cancer	0.000157	0.0012	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Carmustine—brain cancer	0.000157	0.0012	CcSEcCtD
Efavirenz—Dyspnoea—Temozolomide—brain cancer	0.000156	0.00119	CcSEcCtD
Efavirenz—Somnolence—Temozolomide—brain cancer	0.000156	0.00119	CcSEcCtD
Efavirenz—Constipation—Carmustine—brain cancer	0.000155	0.00119	CcSEcCtD
Efavirenz—Pain—Carmustine—brain cancer	0.000155	0.00119	CcSEcCtD
Efavirenz—Malaise—Etoposide—brain cancer	0.000155	0.00118	CcSEcCtD
Efavirenz—Vertigo—Etoposide—brain cancer	0.000154	0.00118	CcSEcCtD
Efavirenz—Dyspepsia—Temozolomide—brain cancer	0.000154	0.00118	CcSEcCtD
Efavirenz—Diarrhoea—Hydroxyurea—brain cancer	0.000153	0.00117	CcSEcCtD
Efavirenz—Decreased appetite—Temozolomide—brain cancer	0.000152	0.00117	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Temozolomide—brain cancer	0.000151	0.00116	CcSEcCtD
Efavirenz—Fatigue—Temozolomide—brain cancer	0.000151	0.00116	CcSEcCtD
Efavirenz—Loss of consciousness—Etoposide—brain cancer	0.000151	0.00115	CcSEcCtD
Efavirenz—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000151	0.0123	CbGpPWpGaD
Efavirenz—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00015	0.0122	CbGpPWpGaD
Efavirenz—Cough—Etoposide—brain cancer	0.00015	0.00115	CcSEcCtD
Efavirenz—Constipation—Temozolomide—brain cancer	0.00015	0.00115	CcSEcCtD
Efavirenz—Pain—Temozolomide—brain cancer	0.00015	0.00115	CcSEcCtD
Efavirenz—Feeling abnormal—Carmustine—brain cancer	0.000149	0.00114	CcSEcCtD
Efavirenz—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000149	0.0122	CbGpPWpGaD
Efavirenz—Convulsion—Etoposide—brain cancer	0.000149	0.00114	CcSEcCtD
Efavirenz—Hypertension—Etoposide—brain cancer	0.000148	0.00113	CcSEcCtD
Efavirenz—Dizziness—Hydroxyurea—brain cancer	0.000148	0.00113	CcSEcCtD
Efavirenz—Gastrointestinal pain—Carmustine—brain cancer	0.000148	0.00113	CcSEcCtD
Efavirenz—Chest pain—Etoposide—brain cancer	0.000146	0.00112	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000145	0.00111	CcSEcCtD
Efavirenz—Discomfort—Etoposide—brain cancer	0.000145	0.00111	CcSEcCtD
Efavirenz—Feeling abnormal—Temozolomide—brain cancer	0.000144	0.0011	CcSEcCtD
Efavirenz—Abdominal pain—Carmustine—brain cancer	0.000143	0.0011	CcSEcCtD
Efavirenz—Body temperature increased—Carmustine—brain cancer	0.000143	0.0011	CcSEcCtD
Efavirenz—Gastrointestinal pain—Temozolomide—brain cancer	0.000143	0.0011	CcSEcCtD
Efavirenz—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000143	0.0117	CbGpPWpGaD
Efavirenz—Vomiting—Hydroxyurea—brain cancer	0.000143	0.00109	CcSEcCtD
Efavirenz—Rash—Hydroxyurea—brain cancer	0.000141	0.00108	CcSEcCtD
Efavirenz—Confusional state—Etoposide—brain cancer	0.000141	0.00108	CcSEcCtD
Efavirenz—Dermatitis—Hydroxyurea—brain cancer	0.000141	0.00108	CcSEcCtD
Efavirenz—Headache—Hydroxyurea—brain cancer	0.000141	0.00107	CcSEcCtD
Efavirenz—Urticaria—Temozolomide—brain cancer	0.000139	0.00106	CcSEcCtD
Efavirenz—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000139	0.0113	CbGpPWpGaD
Efavirenz—Body temperature increased—Temozolomide—brain cancer	0.000139	0.00106	CcSEcCtD
Efavirenz—Abdominal pain—Temozolomide—brain cancer	0.000139	0.00106	CcSEcCtD
Efavirenz—Thrombocytopenia—Etoposide—brain cancer	0.000137	0.00105	CcSEcCtD
Efavirenz—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000137	0.0112	CbGpPWpGaD
Efavirenz—Tachycardia—Etoposide—brain cancer	0.000137	0.00105	CcSEcCtD
Efavirenz—Skin disorder—Etoposide—brain cancer	0.000136	0.00104	CcSEcCtD
Efavirenz—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000136	0.0111	CbGpPWpGaD
Efavirenz—Hyperhidrosis—Etoposide—brain cancer	0.000136	0.00104	CcSEcCtD
Efavirenz—Anorexia—Etoposide—brain cancer	0.000134	0.00102	CcSEcCtD
Efavirenz—Hypersensitivity—Carmustine—brain cancer	0.000134	0.00102	CcSEcCtD
Efavirenz—Nausea—Hydroxyurea—brain cancer	0.000133	0.00102	CcSEcCtD
Efavirenz—Asthenia—Carmustine—brain cancer	0.00013	0.000995	CcSEcCtD
Efavirenz—Hypersensitivity—Temozolomide—brain cancer	0.000129	0.000987	CcSEcCtD
Efavirenz—Paraesthesia—Etoposide—brain cancer	0.000126	0.000963	CcSEcCtD
Efavirenz—Asthenia—Temozolomide—brain cancer	0.000126	0.000962	CcSEcCtD
Efavirenz—Dyspnoea—Etoposide—brain cancer	0.000125	0.000956	CcSEcCtD
Efavirenz—Somnolence—Etoposide—brain cancer	0.000125	0.000953	CcSEcCtD
Efavirenz—Diarrhoea—Carmustine—brain cancer	0.000124	0.000949	CcSEcCtD
Efavirenz—Pruritus—Temozolomide—brain cancer	0.000124	0.000948	CcSEcCtD
Efavirenz—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000122	0.00998	CbGpPWpGaD
Efavirenz—Decreased appetite—Etoposide—brain cancer	0.000122	0.000932	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Etoposide—brain cancer	0.000121	0.000926	CcSEcCtD
Efavirenz—Fatigue—Etoposide—brain cancer	0.000121	0.000925	CcSEcCtD
Efavirenz—Dizziness—Carmustine—brain cancer	0.00012	0.000917	CcSEcCtD
Efavirenz—Constipation—Etoposide—brain cancer	0.00012	0.000917	CcSEcCtD
Efavirenz—Pain—Etoposide—brain cancer	0.00012	0.000917	CcSEcCtD
Efavirenz—Diarrhoea—Temozolomide—brain cancer	0.00012	0.000917	CcSEcCtD
Efavirenz—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000118	0.00959	CbGpPWpGaD
Efavirenz—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000116	0.00947	CbGpPWpGaD
Efavirenz—Dizziness—Temozolomide—brain cancer	0.000116	0.000886	CcSEcCtD
Efavirenz—Feeling abnormal—Etoposide—brain cancer	0.000116	0.000884	CcSEcCtD
Efavirenz—Vomiting—Carmustine—brain cancer	0.000115	0.000882	CcSEcCtD
Efavirenz—Gastrointestinal pain—Etoposide—brain cancer	0.000115	0.000877	CcSEcCtD
Efavirenz—Rash—Carmustine—brain cancer	0.000114	0.000874	CcSEcCtD
Efavirenz—Dermatitis—Carmustine—brain cancer	0.000114	0.000874	CcSEcCtD
Efavirenz—Headache—Carmustine—brain cancer	0.000114	0.000869	CcSEcCtD
Efavirenz—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000112	0.00918	CbGpPWpGaD
Efavirenz—Vomiting—Temozolomide—brain cancer	0.000111	0.000852	CcSEcCtD
Efavirenz—Urticaria—Etoposide—brain cancer	0.000111	0.000852	CcSEcCtD
Efavirenz—Abdominal pain—Etoposide—brain cancer	0.000111	0.000848	CcSEcCtD
Efavirenz—Body temperature increased—Etoposide—brain cancer	0.000111	0.000848	CcSEcCtD
Efavirenz—Rash—Temozolomide—brain cancer	0.00011	0.000845	CcSEcCtD
Efavirenz—Dermatitis—Temozolomide—brain cancer	0.00011	0.000844	CcSEcCtD
Efavirenz—Headache—Temozolomide—brain cancer	0.00011	0.00084	CcSEcCtD
Efavirenz—Nausea—Carmustine—brain cancer	0.000108	0.000824	CcSEcCtD
Efavirenz—Nausea—Temozolomide—brain cancer	0.000104	0.000796	CcSEcCtD
Efavirenz—Hypersensitivity—Etoposide—brain cancer	0.000103	0.00079	CcSEcCtD
Efavirenz—Asthenia—Etoposide—brain cancer	0.000101	0.000769	CcSEcCtD
Efavirenz—Pruritus—Etoposide—brain cancer	9.92e-05	0.000759	CcSEcCtD
Efavirenz—Diarrhoea—Etoposide—brain cancer	9.59e-05	0.000734	CcSEcCtD
Efavirenz—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	9.53e-05	0.00778	CbGpPWpGaD
Efavirenz—Dizziness—Etoposide—brain cancer	9.27e-05	0.000709	CcSEcCtD
Efavirenz—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	9.07e-05	0.00741	CbGpPWpGaD
Efavirenz—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	8.95e-05	0.00731	CbGpPWpGaD
Efavirenz—Vomiting—Etoposide—brain cancer	8.92e-05	0.000682	CcSEcCtD
Efavirenz—Rash—Etoposide—brain cancer	8.84e-05	0.000676	CcSEcCtD
Efavirenz—Dermatitis—Etoposide—brain cancer	8.83e-05	0.000676	CcSEcCtD
Efavirenz—Headache—Etoposide—brain cancer	8.78e-05	0.000672	CcSEcCtD
Efavirenz—CYP2B6—Biological oxidations—CYP2C9—brain cancer	8.6e-05	0.00702	CbGpPWpGaD
Efavirenz—CYP2B6—Metapathway biotransformation—CYP2C9—brain cancer	8.48e-05	0.00692	CbGpPWpGaD
Efavirenz—Nausea—Etoposide—brain cancer	8.33e-05	0.000637	CcSEcCtD
Efavirenz—CYP3A4—Irinotecan Pathway—APC—brain cancer	7.71e-05	0.00629	CbGpPWpGaD
Efavirenz—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	7.36e-05	0.006	CbGpPWpGaD
Efavirenz—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	6.83e-05	0.00558	CbGpPWpGaD
Efavirenz—CYP2C19—Biological oxidations—CYP2C9—brain cancer	6.5e-05	0.0053	CbGpPWpGaD
Efavirenz—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	6.41e-05	0.00523	CbGpPWpGaD
Efavirenz—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	6.27e-05	0.00512	CbGpPWpGaD
Efavirenz—CYP2D6—Biological oxidations—CYP2C9—brain cancer	5.98e-05	0.00488	CbGpPWpGaD
Efavirenz—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	5.89e-05	0.00481	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	5.22e-05	0.00426	CbGpPWpGaD
Efavirenz—CYP1A2—Biological oxidations—CYP2C9—brain cancer	5.06e-05	0.00413	CbGpPWpGaD
Efavirenz—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	4.99e-05	0.00408	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—CYP2C9—brain cancer	3.91e-05	0.00319	CbGpPWpGaD
Efavirenz—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	3.85e-05	0.00314	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	3.01e-05	0.00246	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	2.71e-05	0.00221	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.49e-05	0.00204	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	2.31e-05	0.00188	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	2.12e-05	0.00173	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	2.07e-05	0.00169	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	2.07e-05	0.00169	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	1.94e-05	0.00159	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.82e-05	0.00149	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.66e-05	0.00136	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CYP2C9—brain cancer	1.47e-05	0.0012	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.42e-05	0.00116	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—BSG—brain cancer	1.25e-05	0.00102	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CYP2C9—brain cancer	1.11e-05	0.000907	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—IDH1—brain cancer	1.08e-05	0.000877	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CYP2C9—brain cancer	1.02e-05	0.000834	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—BSG—brain cancer	9.45e-06	0.000771	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—BSG—brain cancer	8.69e-06	0.000709	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP2C9—brain cancer	8.66e-06	0.000707	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—BSG—brain cancer	8.61e-06	0.000703	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ENO2—brain cancer	8.5e-06	0.000694	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—IDH1—brain cancer	8.12e-06	0.000663	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—IDH1—brain cancer	7.47e-06	0.00061	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—IDH1—brain cancer	7.41e-06	0.000605	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—BSG—brain cancer	7.36e-06	0.000601	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP2C9—brain cancer	6.68e-06	0.000545	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.62e-06	0.00054	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ENO2—brain cancer	6.42e-06	0.000524	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—IDH1—brain cancer	6.33e-06	0.000517	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.03e-06	0.000492	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ENO2—brain cancer	5.91e-06	0.000482	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ENO2—brain cancer	5.86e-06	0.000478	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—BSG—brain cancer	5.68e-06	0.000464	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	5.15e-06	0.000421	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ENO2—brain cancer	5e-06	0.000408	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—IDH1—brain cancer	4.89e-06	0.000399	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PIK3CG—brain cancer	3.9e-06	0.000318	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ENO2—brain cancer	3.86e-06	0.000315	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PIK3CG—brain cancer	2.95e-06	0.00024	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PIK3CG—brain cancer	2.71e-06	0.000221	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PIK3CG—brain cancer	2.69e-06	0.000219	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PIK3CG—brain cancer	2.3e-06	0.000187	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PIK3CG—brain cancer	1.77e-06	0.000145	CbGpPWpGaD
